Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.
A review of emerging interactions between OV treatment and the microbiome discusses how microbiome-informed strategies may complement OV-based immunotherapy and highlights the scarcity of longitudinal intratumoral and clinical microbiome data.